Patient perspectives on fluticasone–vilanterol versus other corticosteroid combination products for the treatment of asthma
OBJECTIVE: Fluticasone furoate (FF), an inhaled corticosteroid (ICS), and vilanterol (VI), a long-acting beta(2) receptor agonist (LABA), is a new combination used in an Ellipta(®) device. This article compares FF–VI to other ICS–LABA combinations available, particularly emphasizing product selectio...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874727/ https://www.ncbi.nlm.nih.gov/pubmed/27257375 http://dx.doi.org/10.2147/PPA.S83946 |